(S (NP-SBJ-1 (ADJP-COOD (ADJP Charybdotoxin-sensitive/JJ) ,/, (ADJP Ca-LRB-2+-RRB--dependent/JJ)) membrane/NN potential/JJ changes/NNS) (VP are/VBP not/RB (VP involved/VBN (NP *-1/-NONE-) (PP in/IN (NP human/JJ T/NN or/CC B/NN cell/NN (NP-COOD (NP activation/NN) and/CC (NP proliferation/NN)))))) ./.)
(S (NP-SBJ-2 (NP The/DT involvement/NN) (PP of/IN (NP ion/NN channels/NNS)) (PP in/IN (NP B/NN and/CC T/NN lymphocyte/NN activation/NN))) (VP is/VBZ (VP supported/VBN (NP *-2/-NONE-) (PP by/IN (NP-LGS (NP many/JJ reports/NNS) (PP of/IN (NP (NP changes/NNS) (PP in/IN (NP-COOD (NP ion/NN fluxes/NNS) and/CC (NP membrane/NN potential/NN))) (PP-TMP after/IN (NP mitogen/NN binding/NN)))))))) ./.)
(S (NP-SBJ Human/JJ T/NN and/CC B/NN lymphocytes/NNS) (VP demonstrate/VBP (NP an/DT (ADJP-COOD (ADJP-TMP early/JJ) and/CC (ADJP transient/JJ)) hyperpolarization/NN) (PP-TMP after/IN (NP ligand/JJ binding/NN))) ./.)
(S (SBAR-ADV Inasmuch/RB as/IN (S (NP-SBJ (NP the/DT change/NN) (PP in/IN (NP membrane/NN potential/NN))) (VP is/VBZ (ADJP-PRD dependent/JJ (PP on/IN (NP (NP elevation/NN) (PP of/IN (NP free/JJ cytosolic/JJ calcium/NN)))))))) ,/, (NP-SBJ the/DT hyperpolarization/NN) (VP is/VBZ (ADVP presumably/RB) (PP-PRD through/IN (NP (NP opening/NN) (PP of/IN (NP Ca-LRB-2+-RRB--stimulated/JJ K+/NN channels/NNS))))) ./.)
(S (NP-SBJ-3 We/PRP) (VP have/VBP (VP used/VBN (NP (NP charybdotoxin/NN) ,/, (NP (NP a/DT known/JJ inhibitor/NN) (PP of/IN (NP Ca-LRB-2+-RRB--dependent/JJ K+/NN channels/NNS))) ,/,) (S (NP-SBJ *-3/-NONE-) (VP to/TO (VP study/VB (NP (NP the/DT role/NN) (PP of/IN (NP these/DT channels/NNS)) (PP in/IN (NP lymphocyte/NN (NP-COOD (NP activation/NN) and/CC (NP mitogenesis/NN)))))))))) ./.)
(S (NP-SBJ We/PRP) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ-4 charybdotoxin/NN) (VP inhibits/VBZ (NP (NP the/DT ligand-induced/JJ transient/JJ membrane/NN hyperpolarization/NN) (PP in/IN (NP (NP-COOD (NP B/NN) and/CC (NP T/NN)) cells/NNS))) (PP in/IN (NP a/DT dose-dependent/JJ fashion/NN)) ,/, (PP without/IN (S (NP-SBJ *-4/-NONE-) (VP affecting/VBG (NP (NP changes/NNS) (PP in/IN (NP cytosolic/JJ Ca2+/NN)))))))))) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ-5 (NP blockade/NN) (PP of/IN (NP the/DT Ca-LRB-2+-RRB--activated/JJ K+/NN channel/NN))) (VP is/VBZ not/RB (VP associated/VBN (NP *-5/-NONE-) (PP with/IN (NP (NP changes/NNS) (PP in/IN (NP-COOD (NP cell-cycle/JJ gene/NN activation/NN) ,/, (NP IL-2/NN production/NN) ,/, (NP IL-2R/NN expression/NN) or/CC (NP (NP-COOD (NP B/NN) and/CC (NP T/NN)) cell/NN mitogenesis/NN))))))) ./.)
(S (NP-SBJ These/DT results/NNS) (VP imply/VBP (SBAR that/IN (S (NP-SBJ-6 (NP membrane/NN potential/JJ changes/NNS) (ADJP secondary/JJ (PP to/TO (NP (NP the/DT ligand-dependent/JJ opening/NN) (PP of/IN (NP Ca-LRB-2+-RRB--activated/JJ K+/NN channels/NNS)))))) (VP are/VBP not/RB (VP involved/VBN (NP *-6/-NONE-) (PP in/IN (NP (NP (NP-COOD (NP B/NN) and/CC (NP T/NN)) lymphocyte/NN) (NP-COOD (NP activation/NN) and/CC (NP mitogenesis/NN))))))))) ./.)
